Tumors derived from a mouse model of SCLC exhibited alarmingly low levels of immune infiltration, whereas KRAS- and EGFR-driven NSCLC tended to have robust levels of immune infiltration24. Here, KRAS is linked to non-small cell lung carcinoma.